S&T Bank’s Repligen RGEN Stock Holding History

S&T Bank’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.24K	Buy	36 +24	+200%	+$3.35K	﹤0.01%	335
2025 Q4	$1.97K	Buy	12 +8	+200%	+$1.25K	﹤0.01%	343
2025 Q3	$535	Sell	4 -10	-71%	-$1.22K	﹤0.01%	459
2025 Q2	$1.74K	Buy	+14	New	+$1.78K	﹤0.01%	398

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

S&T Bank's RGEN Position: Q1 2026 in Review

S&T Bank increased its Repligen (RGEN) stake by 200% in Q1 2026, buying an estimated $3.35K and bringing the position to 36 shares worth $4.24K. The position accounts for ﹤0.01% of the portfolio, ranked #335.

S&T Bank first reported a position in RGEN in Q2 2025 and has held it in 4 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

S&T Bank held 36 shares of Repligen worth $4.24K as of Q1 2026.
S&T Bank bought 24 Repligen shares in Q1 2026, an estimated $3.35K.
Repligen made up ﹤0.01% of S&T Bank's portfolio in Q1 2026, its #335 holding.
S&T Bank first reported a position in Repligen in Q2 2025 and has held it in 4 quarters since.
441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on S&T Bank's 13F filing for Q1 2026, filed 13 May 2026.